Laurence Bouillet Selected Research

icatibant

1/2019	Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.
1/2019	Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.
1/2018	Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey.
1/2018	Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.
1/2017	Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
1/2017	Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.
8/2016	A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.
6/2016	The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks.
9/2015	Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
1/2013	Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurence Bouillet Research Topics

Disease

29	Hereditary Angioedemas 03/2022 - 07/2006
26	Angioedema 01/2021 - 09/2004
5	Acquired angioedema 01/2021 - 10/2012
5	Vasculitis (Vasculitides) 10/2019 - 02/2015
4	Chronic Urticaria 10/2021 - 01/2017
4	Edema (Dropsy) 01/2020 - 07/2011
3	Uveitis 10/2020 - 10/2010
3	Urticaria (Hives) 04/2020 - 01/2016
3	Rare Diseases (Rare Disease) 04/2020 - 07/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 01/2016
3	Sarcoidosis (Schaumann Disease) 10/2017 - 01/2017
2	Asthma (Bronchial Asthma) 01/2021 - 01/2016
2	Ocular Toxoplasmosis 10/2020 - 11/2010
2	Hepatitis E 07/2020 - 08/2015
2	Brachial Plexus Neuritis (Parsonage Turner Syndrome) 07/2020 - 08/2015
2	Giant Cell Arteritis (Horton Disease) 01/2020 - 01/2016
2	Neoplasms (Cancer) 01/2020 - 01/2013
2	Infertility (Sterility) 11/2019 - 08/2017
2	Hereditary Angioedema Types I and II 01/2019 - 01/2012
2	Nephritis 01/2018 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 09/2017
2	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2017
2	Abdominal Pain (Pain, Abdominal) 03/2017 - 01/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Cholestasis 07/2020
1	Wounds and Injuries (Trauma) 07/2020
1	Guillain-Barre Syndrome 07/2020
1	Exanthema (Rash) 04/2020
1	Hyperandrogenism 01/2020
1	Mast Cell Activation Disorders (Mast-Cell Disease) 04/2019
1	Leukopenia 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Eosinophilia 01/2018
1	Necrosis 01/2018
1	Overweight 01/2018
1	Arthritis (Polyarthritis) 09/2017
1	Female Infertility 08/2017

Drug/Important Bio-Agent (IBA)

16	BradykininIBA 04/2020 - 02/2008
14	icatibantIBA 01/2019 - 11/2009
6	AntibodiesIBA 10/2020 - 11/2010
5	Pharmaceutical PreparationsIBA 04/2020 - 01/2016
5	cadherin 5IBA 08/2014 - 07/2011
4	AndrogensIBA 01/2022 - 02/2008
4	Biological ProductsIBA 10/2020 - 05/2014
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2020 - 02/2008
4	AutoantibodiesIBA 11/2019 - 10/2012
4	Rituximab (Mabthera)FDA Link 01/2018 - 10/2012
4	tocilizumab (atlizumab)FDA Link 01/2018 - 01/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2016 - 02/2008
3	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2021 - 11/2008
3	Omalizumab (Xolair)FDA Link 02/2021 - 01/2016
3	Estrogens (Estrogen)FDA Link 01/2021 - 10/2014
3	Histamine Antagonists (Antihistamines)IBA 01/2019 - 01/2014
3	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2013
2	lanadelumabIBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 10/2020 - 11/2010
2	RNA (Ribonucleic Acid)IBA 07/2020 - 08/2015
2	Immunoglobulin M (IgM)IBA 07/2020 - 08/2015
2	Hormones (Hormone)IBA 01/2020 - 09/2004
2	PlasminogenIBA 01/2020 - 11/2018
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019 - 01/2018
2	GlucocorticoidsIBA 01/2019 - 01/2014
2	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2016
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 09/2017
2	Infliximab (Remicade)FDA Link 10/2017 - 01/2017
2	SteroidsIBA 01/2016 - 06/2015
2	KininsIBA 06/2015 - 02/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 01/2013
2	Metalloproteases (Metalloproteinases)IBA 01/2013 - 02/2008
2	Bradykinin Receptor AntagonistsIBA 01/2012 - 08/2010
2	Danazol (Azol)FDA LinkGeneric 03/2007 - 07/2006
1	Retinaldehyde (Retinal)IBA 10/2020
1	Transaminases (Aminotransferases)IBA 07/2020
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2020
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2020
1	Factor XII (Hageman Factor)IBA 01/2020
1	Antinuclear AntibodiesIBA 11/2019
1	Interleukin-1 (Interleukin 1)IBA 10/2019
1	Opioid Analgesics (Opioids)IBA 04/2019
1	Interferon Type IIBA 01/2019
1	Protein Phosphatase 1IBA 01/2019
1	levocetirizine FDA LinkGeneric 01/2019
1	Levamisole (Decaris)FDA Link 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2018
1	Abatacept (Orencia)FDA Link 01/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018
1	LactamsIBA 01/2018
1	Antirheumatic Agents (DMARD)IBA 01/2018
1	Thyroglobulin FDA Link 08/2017
1	Immunologic Factors (Immunomodulators)IBA 08/2017

Therapy/Procedure

5	Therapeutics 03/2022 - 06/2007
1	Contraception (Birth Control) 01/2020
1	Immunomodulation 11/2019
1	Off-Label Use 10/2017
1	Anesthesia 03/2017